Diagnostics of Messenger Ribonucleic Acid (mRNA) Severe Acute Respiratory Syndrome-corona Virus‑2 (SARS-CoV‑2) Vaccination-associated Myocarditis-A systematic Review

Overview

Journal Rechtsmedizin (Berl)

Specialty Forensic Sciences

Date 2022 Jul 25

PMID 35873498

Authors

Jan M Federspiel

Frank Ramsthaler

Mattias Kettner

Gerhard Mall

Affiliations

Soon will be listed here.

Abstract

Background: During the recent pandemic with the severe acute respiratory syndrome-corona virus‑2 the first messenger ribonucleic acid (mRNA) vaccines were approved. To facilitate mass vaccination, confidence of the general population in these new vaccines is mandatory, which is in turn strongly dependent on the availability of reliable data on complications.

Objective: Summary of the current knowledge on mRNA vaccination-associated myocarditis as a potentially fatal side effect.

Methods: Systematic literature review.

Results: Diagnostic algorithm for the postmortem diagnosis of mRNA vaccination-associated myocarditis.

Conclusion: Autopsy series of fatalities following mRNA SARS-CoV‑2 vaccination up to 6 weeks with subsequent sophisticated and interdisciplinary work-up are necessary to complement clinical data on vaccination-associated myocarditis, especially regarding the incidence of fatal courses.

Supplementary Information: The online version of this article (10.1007/s00194-022-00587-9) includes a PDF file with supplemental clinical features.

Citing Articles

A Case Report: Long Post-COVID Vaccination Syndrome During the Eleven Months After the Third Moderna Dose.

Finsterer J Cureus. 2023; 14(12):e32433.

PMID: 36644105 PMC: 9833629. DOI: 10.7759/cureus.32433.

References

Chakraborty C, Sharma A, Bhattacharya M, Lee S . From COVID-19 to Cancer mRNA Vaccines: Moving From Bench to Clinic in the Vaccine Landscape. Front Immunol. 2021; 12:679344. PMC: 8293291. DOI: 10.3389/fimmu.2021.679344. View

Fisman D, Tuite A . Evaluation of the relative virulence of novel SARS-CoV-2 variants: a retrospective cohort study in Ontario, Canada. CMAJ. 2021; 193(42):E1619-E1625. PMC: 8562985. DOI: 10.1503/cmaj.211248. View

Chamling B, Vehof V, Drakos S, Weil M, Stalling P, Vahlhaus C . Occurrence of acute infarct-like myocarditis following COVID-19 vaccination: just an accidental co-incidence or rather vaccination-associated autoimmune myocarditis?. Clin Res Cardiol. 2021; 110(11):1850-1854. PMC: 8325525. DOI: 10.1007/s00392-021-01916-w. View

Caredda G . Editorial Comment: Cardiac MRI as a Fundamental Tool in the Evaluation of Suspected Myocarditis After COVID-19 mRNA Vaccination in Young Patients. AJR Am J Roentgenol. 2021; 218(4):658. DOI: 10.2214/AJR.21.27026. View

Chia P, Ong S, Chiew C, Ang L, Chavatte J, Mak T . Virological and serological kinetics of SARS-CoV-2 Delta variant vaccine breakthrough infections: a multicentre cohort study. Clin Microbiol Infect. 2021; 28(4):612.e1-612.e7. PMC: 8608661. DOI: 10.1016/j.cmi.2021.11.010. View

Amanna I, Slifka M . Public fear of vaccination: separating fact from fiction. Viral Immunol. 2005; 18(2):307-15. DOI: 10.1089/vim.2005.18.307. View

Shaw K, Cavalcante J, Han B, Gossl M . Possible Association Between COVID-19 Vaccine and Myocarditis: Clinical and CMR Findings. JACC Cardiovasc Imaging. 2021; 14(9):1856-1861. PMC: 8245050. DOI: 10.1016/j.jcmg.2021.06.002. View

Verma A, Lavine K, Lin C . Myocarditis after Covid-19 mRNA Vaccination. N Engl J Med. 2021; 385(14):1332-1334. PMC: 8385564. DOI: 10.1056/NEJMc2109975. View

Chow L, Radio S, Sears T, McManus B . Insensitivity of right ventricular endomyocardial biopsy in the diagnosis of myocarditis. J Am Coll Cardiol. 1989; 14(4):915-20. DOI: 10.1016/0735-1097(89)90465-8. View

10.

Albert E, Aurigemma G, Saucedo J, Gerson D . Myocarditis following COVID-19 vaccination. Radiol Case Rep. 2021; 16(8):2142-2145. PMC: 8130498. DOI: 10.1016/j.radcr.2021.05.033. View

11.

Witberg G, Barda N, Hoss S, Richter I, Wiessman M, Aviv Y . Myocarditis after Covid-19 Vaccination in a Large Health Care Organization. N Engl J Med. 2021; 385(23):2132-2139. PMC: 8531986. DOI: 10.1056/NEJMoa2110737. View

12.

Olbrich H . [Epidemiology-etiology of dilated cardiomyopathy]. Z Kardiol. 2001; 90 Suppl 1:2-9. DOI: 10.1007/s003920170052. View

13.

Engler R, Nelson M, Collins Jr L, Spooner C, Hemann B, Gibbs B . A prospective study of the incidence of myocarditis/pericarditis and new onset cardiac symptoms following smallpox and influenza vaccination. PLoS One. 2015; 10(3):e0118283. PMC: 4368609. DOI: 10.1371/journal.pone.0118283. View

14.

Horby P, Lim W, Emberson J, Mafham M, Bell J, Linsell L . Dexamethasone in Hospitalized Patients with Covid-19. N Engl J Med. 2020; 384(8):693-704. PMC: 7383595. DOI: 10.1056/NEJMoa2021436. View

15.

Kim H, Jenista E, Wendell D, Azevedo C, Campbell M, Darty S . Patients With Acute Myocarditis Following mRNA COVID-19 Vaccination. JAMA Cardiol. 2021; 6(10):1196-1201. PMC: 8243258. DOI: 10.1001/jamacardio.2021.2828. View

16.

Chen W, Jeudy J . Assessment of Myocarditis: Cardiac MR, PET/CT, or PET/MR?. Curr Cardiol Rep. 2019; 21(8):76. DOI: 10.1007/s11886-019-1158-0. View

17.

Hudson B, Mantooth R, DeLaney M . Myocarditis and pericarditis after vaccination for COVID-19. J Am Coll Emerg Physicians Open. 2021; 2(4):e12498. PMC: 8313036. DOI: 10.1002/emp2.12498. View

18.

Sokolska J, Kurcz J, Kosmala W . Every rose has its thorns - acute myocarditis following COVID-19 vaccination. Kardiol Pol. 2021; 79(10):1153-1154. DOI: 10.33963/KP.a2021.0075. View

19.

Suzuki Y, Ishihara H . Difference in the lipid nanoparticle technology employed in three approved siRNA (Patisiran) and mRNA (COVID-19 vaccine) drugs. Drug Metab Pharmacokinet. 2021; 41:100424. PMC: 8502116. DOI: 10.1016/j.dmpk.2021.100424. View

20.

Shanes J, Ghali J, Billingham M, Ferrans V, Fenoglio J, Edwards W . Interobserver variability in the pathologic interpretation of endomyocardial biopsy results. Circulation. 1987; 75(2):401-5. DOI: 10.1161/01.cir.75.2.401. View